Massive study aims to uncover hidden cause of high blood pressure

NCT ID NCT07378176

Recruiting now Knowledge-focused Sponsor: Xinjiang Medical University Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study follows 5,000 people with primary aldosteronism, a common but often missed cause of high blood pressure that raises heart and kidney risks. Researchers will track treatments like medication, surgery, and other procedures over five years to see which works best. The goal is to provide real-world evidence to improve diagnosis and long-term care.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this study could provide better guidelines for diagnosing and treating primary aldosteronism, potentially reducing heart and kidney complications.
What could go wrong: This is an observational study, not a treatment trial. It will not directly test a new therapy, and results may take years to influence practice.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PRIMARY ALDOSTERONISM are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

hyperaldosteronism primary aldosteronism

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

PRIMARY ALDOSTERONISM

Contacts and locations

Locations

The First Affiliated Hospital of Chengdu Medical College
RECRUITING

Chengdu, Sichuan, 610000, China
The First Affiliated Hospital of Xinjiang Medical University
RECRUITING

Ürümqi, Xinjiang, 830000, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.